Thorne Healthtech Inc (THRN) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket
 


Thorne Healthtech Inc   (NASDAQ: THRN)


Thorne Healthtech Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Thorne Healthtech Inc 's ROA in the second quarter of 2023?
Thorne Healthtech Inc achieved a return on average assets (ROA) of 9.22 % in its second quarter of 2023, this is above THRN's average return on assets of 4.41%.
Thorne Healthtech Inc assets over the 12 months ending in its second quarter of 2023 are valued at $215 million

ROA has improved compared to 4.94% in the first quarter of 2023, due to net income growth.

However, within the Healthcare sector 90 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2023 quarter, so far to 830, from total ROA ranking in the first quarter of 2023 at 1399.

What is ROA?



Return On Assets (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Total Assets Change 42.05 % 30.65 % 32.15 % -0.77 % 73.61 %
Y / Y Net Income Change - - 715.5 % 277.24 % -
Net Income (TTM) in million 20 10 15 4 1
Return On Assets (TTM) 9.22 % 4.94 % 8.15 % 2.38 % 0.83 %
THRN's Total Ranking # 830 # 1399 # 1161 # 2185 # 3326
Total Assets (TTM) in million 249 223 211 176 175
Seq. Total Assets Change 11.68 % 5.68 % 20.14 % 0.18 % 2.72 %
Seq. Net Income Change - - 245.75 % - -



Return On Assets Company Ranking
Within: No.
Industry # 43
Sector # 91
Overall # 817

Return On Assets Statistics
High Average Low
8.38 %
4.41 %
-0.57 %
(Jun 30 2023)   (Jun 30 2022)





Financial Statements
Thorne Healthtech Inc 's Assets $ 249 million THRN's Balance sheet
Thorne Healthtech Inc 's Income $ 4 million Quarterly THRN's Income Statement
THRN's Income by Division See THRN's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021

FY

FY

FY
Y / Y Total Assets Change 32.15 % - - - -
Total Assets in million 211 160 0 0 0
Y / Y Net Income Change 118.16 % - - - -
Net Income in million 15 7 0 0 0
Annual Return On Assets 7.07 % 4.29 % - - -




Comment on THRN's ROA in the fiscal year ending 2022
In the fiscal year 2022 ROA improved to 7.07 % compared to prior year, due to annual net income growth of 118.16 % to $14.93 million, while value of Thorne Healthtech Inc 's overall assets grew just by 32.15 % to $211.07 million, compared to $211.07 a year before.


More Return On Assets Ratios
THRN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
THRN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for THRN's Competitors
Subscribers only: Roa for Thorne Healthtech Inc 's Suppliers
Subscribers only: Return On Assets for THRN's Customers

You may also want to know
THRN's Roi THRN's Inventory Turnover Ratio THRN's Growth Rates THRN's Dividend Comparisons
THRN's Profitability Ratios THRN's Asset Turnover Ratio THRN's Dividend Growth
THRN's Roe THRN's Valuation Ratios THRN's Financial Strength Ratios THRN's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector ROA
Assertio Holdings inc   25.11 %
Mettler toledo International Inc   23.92 %
Denali Therapeutics Inc   23.85 %
Enzo Biochem Inc  22.82 %
Nrc Health  21.88 %
Waters Corporation  21.66 %
Agile Therapeutics Inc  21.11 %
Revelation Biosciences Inc   20.17 %
Point Biopharma Global Inc   19.86 %
Medpace Holdings Inc   19.60 %
Arcturus Therapeutics Holdings Inc   19.52 %
Vaso Corporation  19.38 %
Fuse Medical Inc   18.93 %
Iradimed Corporation  18.24 %
Vertex Pharmaceuticals Inc  18.14 %
Pro dex Inc   17.44 %
Corcept Therapeutics Inc  16.69 %
Innoviva Inc   16.41 %
Edwards Lifesciences Corporation  16.05 %
Chemed Corporation  15.80 %
Zoetis Inc   15.75 %
Siga Technologies Inc  15.59 %
Resmed Inc   15.12 %
Regeneron Pharmaceuticals Inc   14.62 %
One World Products Inc   14.51 %
West Pharmaceutical Services Inc   14.48 %
United Therapeutics Corporation  14.03 %
Zynex inc   13.92 %
Utah Medical Products Inc  13.78 %
Atrion Corporation  13.60 %


Date modified: 2026-08-29T17:45:27+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.